Unknown

Dataset Information

0

Repurposing antiviral agents against mucormycosis

ABSTRACT:

SUBMITTER: Khan A 

PROVIDER: S-EPMC12915971 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents.
| S-EPMC9123807 | biostudies-literature
Unknown Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.
| S-EPMC4692129 | biostudies-literature
Unknown Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease.
| S-EPMC8652770 | biostudies-literature
Unknown Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
| S-EPMC7250111 | biostudies-literature
Unknown Molecular Mechanisms of Antiviral Agents against Dengue Virus.
| S-EPMC10056858 | biostudies-literature
Unknown Antiviral Agents against Flavivirus Protease: Prospect and Future Direction.
| S-EPMC8955721 | biostudies-literature
Unknown Historical perspectives in the development of antiviral agents against poxviruses.
| S-EPMC3185982 | biostudies-literature
Unknown Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75.
| S-EPMC9511631 | biostudies-literature
Unknown Efavirenz Repurposing Challenges: A Novel Nanomicelle-Based Antiviral Therapy Against Mosquito-Borne Flaviviruses.
| S-EPMC11859092 | biostudies-literature
Unknown Repurposing Vancomycin as a Potential Antiviral Agent Against PEDV via nsp13 Helicase Inhibition.
| S-EPMC11987754 | biostudies-literature